PROTECTIVE ACTIVITY OF THE LIPID-A ANALOG GLA-60 AGAINST MURINE CYTOMEGALOVIRUS-INFECTION IN IMMUNODEFICIENT MICE

被引:6
作者
IKEDA, S
NEYTS, J
MATSUURA, M
KISO, M
HASEGAWA, A
NISHIMURA, C
DECLERCQ, E
机构
[1] KITASATO UNIV,SCH PHARMACEUT SCI,TOKYO 108,JAPAN
[2] JICHI MED SCH,MINAMI KAWACHI,TOCHIGI 32904,JAPAN
[3] GIFU UNIV,FAC AGR,GIFU 50111,JAPAN
关键词
D O I
10.1099/0022-1317-74-7-1399
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
The immunomodulating and murine cytomegalovirus (MCMV)-inhibiting effects of the synthetic lipid A subunit analogue GLA-60 were investigated in different strains of immunodeficient mice. Peritoneal natural killer (NK) cells obtained from nude (nu/nu) C57BL/6 mice or normal NMRI mice, which had been treated intraperitoneally with 10 mug of GLA-60 1 day earlier, exhibited a greater cytolytic activity than those from untreated mice. GLA-60 also stimulated NK cell activity in SCID (severe combined immune deficiency) mice (which are T and B cell-defective), but not in NK cell-defective beige (C57BL/6 bg/bg) mice. GLA-60 also enhanced the phagocytic activity of peritoneal macrophages in beige, nude and NMRI mice, but not in SCID mice. GLA-60, when administered as a single 150 mug dose 1 day before infection, completely protected beige mice against MCMV-associated mortality. It also caused a significant increase in the life-span of MCMV-infected nude and SCID mice.
引用
收藏
页码:1399 / 1403
页数:5
相关论文
共 34 条
[1]   PROTECTIVE EFFECT OF EARLY SERUM FROM MICE AFTER CYTOMEGALOVIRUS-INFECTION [J].
ARAULLOCRUZ, TP ;
HO, M ;
ARMSTRONG, JA .
INFECTION AND IMMUNITY, 1978, 21 (03) :840-842
[2]   A SEVERE COMBINED IMMUNODEFICIENCY MUTATION IN THE MOUSE [J].
BOSMA, GC ;
CUSTER, RP ;
BOSMA, MJ .
NATURE, 1983, 301 (5900) :527-530
[3]  
BRITT WJ, 1991, TRANSPLANT P, V23, P115
[4]  
EMANUEL D, 1990, SEMIN HEMATOL, V27, P22
[5]   PROGRESSIVE DISEASE DUE TO GANCICLOVIR-RESISTANT CYTOMEGALO-VIRUS IN IMMUNOCOMPROMISED PATIENTS [J].
ERICE, A ;
CHOU, S ;
BIRON, KK ;
STANAT, SC ;
BALFOUR, HH ;
JORDAN, MC .
NEW ENGLAND JOURNAL OF MEDICINE, 1989, 320 (05) :289-293
[6]   ENHANCEMENT OF NONSPECIFIC RESISTANCE TO VIRAL-INFECTION BY CHEMICALLY SYNTHESIZED LIPID A-SUBUNIT ANALOGS WITH DIFFERENT BACKBONE STRUCTURES AND ACYL-GROUPS [J].
IKEDA, S ;
KUMAZAWA, Y ;
NISHIMURA, C ;
NAKATSUKA, M ;
HOMMA, JY ;
KISO, M ;
HASEGAWA, A .
ANTIVIRAL RESEARCH, 1988, 10 (4-5) :167-178
[7]   ANTIVIRAL AND IMMUNOMODULATING ACTIVITIES OF CHEMICALLY SYNTHESIZED LIPID A-SUBUNIT ANALOGS GLA-27 AND GLA-60 [J].
IKEDA, S ;
NISHIMURA, C ;
NAKATSUKA, M ;
HOMMA, JY ;
KISO, M ;
HASEGAWA, A .
ANTIVIRAL RESEARCH, 1988, 9 (1-2) :37-46
[8]  
IKEDA S, 1990, J CLIN LAB IMMUNOL, V32, P189
[9]   ANTIHERPES ACTIVITY OF CHEMICALLY SYNTHESIZED LIPID A-SUBUNIT ANALOG GLA-60 IN IMMUNOSUPPRESSED MICE [J].
IKEDA, S ;
TOMINAGA, T ;
NISHIMURA, C ;
HOMMA, JY ;
KISO, M ;
HASEGAWA, A .
ANTIVIRAL RESEARCH, 1989, 11 (04) :173-180
[10]  
IKEDA S, 1993, IN PRESS J MED VIROL